LobbyingInfusion Providers Alliance lobbying by quarter
Infusion Providers Alliance's latest lobbying report covers Q2 2026, at $200K. The four quarters Q4 2025–Q3 2026 total $600K. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid and Health Issues.
Infusion Providers Alliance
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $600K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $107K | 2 |
| Q1 2023 | $107K | 2 |
| Q2 2023 | $107K | 2 |
| Q3 2023 | $107K | 2 |
| Q4 2023 | $107K | 2 |
| Q1 2024 | $107K | 2 |
| Q2 2024 | $107K | 2 |
| Q3 2024 | $107K | 2 |
| Q4 2024 | $107K | 2 |
| Q1 2025 | $120K | 2 |
| Q2 2025 | $190K | 2 |
| Q3 2025 | $200K | 2 |
| Q4 2025 | $200K | 2 |
| Q1 2026 | $200K | 2 |
| Q2 2026 | $200K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Medicare and Medicaid$1.1M · 30 reports
- Health issues$983K · 28 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES30 reports
- SENATE30 reports
- Centers For Medicare and Medicaid Services (CMS)27 reports
- Medicare Payment Advisory Commission (MedPAC)13 reports
Firms it paid
| Firm | ||
|---|---|---|
| The McManus Group | $1.3M | 15 quarters |
| In-houseInfusion Providers Alliance | $813K | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JOHN MCMANUS | Staff Director, W&M Health Subcommittee. LA, Rep. Bill Thomas. | Q2 2026 |
| BRAD TRAVERSE | Former Senior Advisor, Office of the HHS Assistant Secretary of Public Affairs | Q1 2025 |
| ALANNA TEMME | LD, Rep. Jon Porter. | Q4 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | The McManus Group | $90K |
| 07/20for Q2 | In-house | $110K |
| 04/20for Q1 | The McManus Group | $90K |
| 04/20for Q1 | In-house | $110K |
| 01/20for Q4 2025 | In-house | $110K |
| 01/20for Q4 2025 | The McManus Group | $90K |
| 25/10/20for Q3 2025 | The McManus Group | $90K |
| 25/10/20for Q3 2025 | In-house | $110K |
| 25/07/21for Q2 2025 | The McManus Group | $90K |
| 25/07/18for Q2 2025 | In-house | $100K |
| 25/04/21for Q1 2025 | In-house | $30K |
| 25/04/21for Q1 2025 | The McManus Group | $90K |
| 25/01/21for Q4 2024 | The McManus Group | $80K |
| 25/01/20for Q4 2024 | In-house | $27K |
| 24/10/21for Q3 2024 | The McManus Group | $80K |
| 24/10/18for Q3 2024 | In-house | $27K |
| 24/07/18for Q2 2024 | The McManus Group | $80K |
| 24/07/16for Q2 2024 | In-house | $27K |
| 24/04/22for Q1 2024 | The McManus Group | $80K |
| 24/03/22for Q1 2024 | In-house | $27K |